Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, announces the appointment of Dr. Klaus Edvardsen as its new Chief Medical ...

Sanofi announced its intention to execute a share buyback program in 2025 of €5 billion, preferably through block trades and in the open market with the purpose of cancellation. A first tranche of ...

In an industry-defining moment, Accumulus Synergy (“Accumulus”) has powered Amgen’s groundbreaking regulatory submission: the first-ever, digitally generated Chemistry, Manufacturing, and Controls ...

Researchers have created a remarkable new map of a key part of our brain, the hypothalamus, that will lead to new ways of controlling our weight, appetite, sleep and stress levels. Health and wellness ...

Clinigen, the global speciality pharmaceutical services group, and Essential Pharma, an international specialty pharmaceutical group, today announced an expansion of their JAPAC collaboration, aimed ...

Syncona Ltd (”Syncona”), a leading life science investor focused on creating, building and scaling a portfolio of global leaders in life science, today issues its quarterly update covering the period ...